Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Lifecore Biomedical, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 104 | 1 | 105 | +2 |
| Shares | 24.8M | 1.67M | 25.1M | +2.00M (+8.6%) |
| Value | $202.8M | $13.7M | $93.4M | −$95.7M (−50.6%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Lifecore Biomedical, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,290,136 | $4.80M | 0.00% |
| Vanguard Fiduciary Trust Co | 237,065 | $881.9K | 0.00% |
| Vanguard Portfolio Management LLC | 164,560 | $612.2K | 0.00% |
| Qube Research & Technologies Ltd | 75,097 | $279.4K | 0.00% |
| Jefferies Financial Group Inc. | 32,500 | $120.9K | 0.00% |
| Engineers Gate Manager LP | 24,700 | $91.9K | 0.00% |
| Dynamic Technology Lab Private Ltd | 20,375 | $75.8K | 0.01% |
| SG Americas Securities, LLC | 17,279 | $64.0K | 0.00% |
| Vanguard Global Advisers, LLC | 16,348 | $60.8K | 0.00% |
| Mraz, Amerine & Associates, Inc. | 15,625 | $58.1K | 0.01% |
| Warberg Asset Management LLC | 15,000 | $55.8K | 0.02% |
| XTX Topco Ltd | 14,952 | $55.6K | 0.00% |
| nVerses Capital, LLC | 10,027 | $37.3K | 0.03% |
| one8zero8, LLC | 10,000 | $37.2K | 0.01% |
| Meeder Asset Management Inc | 2,873 | $10.7K | 0.00% |
| Hurley Capital, LLC | 1,148 | $4.27K | 0.00% |
| Harbour Investments, Inc. | 725 | $2.70K | 0.00% |
| Advisor Group Holdings, Inc. | 343 | $1.27K | 0.00% |
| Transamerica Financial Advisors, Inc. | 51 | $189 | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | $19 | 0.00% |
Sold out (18)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 119,445 | $977.1K |
| Pale Fire Capital SE | 71,040 | $581.1K |
| D. E. Shaw & Co., Inc. | 37,428 | $306.2K |
| Two Sigma Investments, LP | 27,803 | $227.4K |
| PharVision Advisers, LLC | 19,041 | $155.8K |
| Citadel Advisors LLC | 18,116 | $148.2K |
| Two Sigma Advisers, LP | 15,264 | $124.9K |
| Jump Financial, LLC | 15,061 | $123.2K |
| Graham Capital Management, L.P. | 13,580 | $111.1K |
| Intech Investment Management LLC | 11,724 | $95.9K |
| MetLife Investment Management | 10,660 | $87.2K |
| Torren Management, LLC | 2,312 | $18.9K |
| Arbor Wealth Management LLC | 1,674 | $13.7K |
| Quarry LP | 1,400 | $11.5K |
| Kemnay Advisory Services Inc. | 975 | $7.98K |
| Amalgamated Bank | 877 | $7.00K |
| Jones Financial Companies LLLP | 23 | $188 |
| SRS Capital Advisors, Inc. | 5 | $41 |
Not filed for Q1 2026 yet (1)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,673,666 | $13.7M |